TriSalus Life Sciences Warrant
TLSIW
7 hedge funds and large institutions have $1.23M invested in TriSalus Life Sciences Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
13% less funds holding
Funds holding: 8 → 7 (-1)
30% less capital invested
Capital invested by funds: $1.77M → $1.23M (-$537K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$741 |
| 2 |
Rockefeller Capital Management
New York
|
+$67 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Cerity Partners
New York
| $993K | – | – | – |
|
|
VI
2
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $85K | – | – | – |
|
3
Citadel Advisors
Miami,
Florida
| $78.2K | -$17.6K | -13,093 | -17% |
|
|
AC
4
Aristeia Capital
Greenwich,
Connecticut
| $35.8K | +$741 | +550 | +2% |
|
|
FBCM
5
Fort Baker Capital Management
Larkspur,
California
| $31.6K | -$135 | -100 | -0.4% |
|
6
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $6.46K | – | – | – |
|
|
7
Rockefeller Capital Management
New York
| $60 | +$67 | +50 | New |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| – | -$51.4K | -30,990 | Closed |
|
9
Bank of America
Charlotte,
North Carolina
| – | -$1.68K | -1,009 | Closed |
|
TLSIW Hedge Fund Activity: Q1 2026 in Review
7 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2026, worth a combined $1.23M — down 30% from $1.77M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TLSIW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Aristeia Capital, adding an estimated $741. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $51.4K sold.
- 7 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2026, down from 8 in Q4 2025.
- Funds reported $1.23M of TriSalus Life Sciences Warrant stock for Q1 2026, down 30% quarter-over-quarter.
- 1 fund opened new TriSalus Life Sciences Warrant positions in Q1 2026 and 2 closed out, a net change of -1 holder.
- The largest TriSalus Life Sciences Warrant buyer in Q1 2026 was Aristeia Capital, an estimated $741 added.
- The largest TriSalus Life Sciences Warrant seller in Q1 2026 was Wolverine Asset Management, an estimated $51.4K sold.
Based on aggregated 13F filings for Q1 2026.